globalbarry. Company Intelligence Engine

Celldex Therapeutics, Inc.

CLDX CIK 0000744218 · In Vitro & In Vivo Diagnostic Substances (SIC 2835)

Disclosed SEC business address
53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827

Celldex Therapeutics, Inc. (ticker CLDX, CIK 0000744218) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: In Vitro & In Vivo Diagnostic Substances (SIC 2835). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.

1,100 exposure relationships mapped 94 related entities (events · industries · countries) Intelligence last refreshed 2026-11-04

Top findings public preview

  • FACT Disclosed industry: In Vitro & In Vivo Diagnostic Substances (SIC 2835)
  • FACT Country of disclosed business address: United States
  • FACT SCHEDULE 13G/A filed 2026-10-07 source ↗

Go deeper

This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 1 free company deep view left this month.

Sources

Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.